NCT00113581 2014-02-19Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric CancerMerck KGaA, Darmstadt, GermanyPhase 1 Completed26 enrolled